
Avantor reported a 4.6% increase in net sales to $1.7 billion for Q3 2026, driven by organic growth of 5.2%. The company posted a diluted GAAP EPS of $0.30 and adjusted EPS of $0.22, surpassing management expectations. Strong performance in VWR Distribution & Services and Bioscience & Medtech Products segments supported the growth. Avantor raised its full-year 2026 guidance for organic revenue growth, adjusted EPS, and free cash flow, signaling confidence in continued momentum.
Avantor Inc. shares trade at USD 16.85 on Pluang as of Oct 28, 2026 17:11 WIB, down 1.63% for the day. The stock's market cap stands at $11.59 billion with a 52-week high of $17.29. Investors hold shares for an average of 11 days on the platform.